journal article·2025-02Open access

SPP1‐ITGα5/β1 Accelerates Calcification of Nucleus Pulposus Cells by Inhibiting Mitophagy via Ubiquitin‐Dependent PINK1/PARKIN Pathway Blockade

Hanwen Gu, Qi Li, Zhenchuan Liu, Yanlin Li, Kaiwen Liu, Xiangzhen Kong, Yuanqiang Zhang, Qunbo Meng, Kangle Song, Qing Xie, Yuan Gao, Lei Cheng

Advanced Science· Volume 12· Issue 7

Abstract

Abstract Low back pain (LBP) caused by nucleus pulposus degeneration and calcification leads to great economic and social burden worldwide. Unexpectedly, no previous studies have demonstrated the association and the underlying mechanism between nucleus pulposus tissue degeneration and calcification formation. Secreted Phosphoprotein 1 (SPP1) exerts crucial functions in bone matrix mineralization and calcium deposition. Here, a novel function of SPP1 is reported, namely that it can aggravate nucleus pulposus cells (NPs) degeneration by negatively regulating extracellular matrix homeostasis. The degenerated NPs have a higher mineralization potential, which is achieved by SPP1. Mechanistically, SPP1 can accelerate the degeneration of nucleus pulposus cells by activating integrin α5β1 (ITGα5/β1), aggravating mitochondrial damage and inhibiting mitophagy. SPP1‐ITGα5/β1 axis inhibits mitophagy by PINK1/PARKIN pathway blockade. In conclusion, SPP1 activates ITGα5/β1 to inhibit mitophagy, accelerates NPs degeneration, and induces calcification, thereby leading to intervertebral disc degeneration (IVDD) and calcification, identifying the potentially unknown mechanism and relationship between IVDD and calcification. Important insights are provided into the role of SPP1 in nucleus pulposus calcification in IVDD by inducing nucleus pulposus cell senescence through inhibition of mitophagy and may help develop potential new strategies for IVDD treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spine and Intervertebral Disc Pathology · Pain Mechanisms and Treatments · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedic Qilu Hospital of Shandong University Jinan Shandong 250012 China

Department of Pharmacy Qilu Hospital Cheeloo College of Medicine Shandong University Jinan 250012 China

Funding

National Natural Science Foundation of China · Natural Science Foundation of Shandong Province

References (55)

Show source-provided references
1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, Lancet · 2018 · 392 · 1789
2. 10.1016/S0140-6736(99)01312-410.1016/S0140-6736(99)01312-4 ↗
3. 10.1038/s41584-022-00783-710.1038/s41584-022-00783-7 ↗
4. 10.1186/s12891-016-1015-x10.1186/s12891-016-1015-x ↗
5. 10.1016/0002-9149(91)90933-C10.1016/0002-9149(91)90933-C ↗
6. 10.1186/s13028-019-0448-210.1186/s13028-019-0448-2 ↗
7. 10.1038/s41556-018-0176-210.1038/s41556-018-0176-2 ↗
8. 10.1016/j.biomaterials.2024.12276410.1016/j.biomaterials.2024.122764 ↗
9. 10.1080/15548627.2022.216224510.1080/15548627.2022.2162245 ↗
10. 10.1080/15548627.2023.227420510.1080/15548627.2023.2274205 ↗
11. 10.1002/hep.3158210.1002/hep.31582 ↗
12. 10.1002/advs.20220629610.1002/advs.202206296 ↗
13. 10.1089/scd.2014.028210.1089/scd.2014.0282 ↗
14. 10.1007/s10753-024-02020-710.1007/s10753-024-02020-7 ↗
15. 10.3389/fimmu.2022.93372110.3389/fimmu.2022.933721 ↗
16. 10.1016/j.isci.2023.10669210.1016/j.isci.2023.106692 ↗
17. 10.3390/ijms2307399310.3390/ijms23073993 ↗
18. 10.1038/s41573-021-00284-410.1038/s41573-021-00284-4 ↗
19. 10.1097/BRS.000000000000185610.1097/BRS.0000000000001856 ↗
20. 10.3389/fcell.2021.83342010.3389/fcell.2021.833420 ↗
21. 10.1148/radiol.230201184210.1148/radiol.2302011842 ↗
22. 10.3389/fendo.2022.101250810.3389/fendo.2022.1012508 ↗
23. 10.1016/j.redox.2017.01.01310.1016/j.redox.2017.01.013 ↗
24. 10.1016/S0140-6736(21)00733-910.1016/S0140-6736(21)00733-9 ↗
25. 10.1056/NEJMcp151265810.1056/NEJMcp1512658 ↗
26. 10.1056/NEJMoa191265810.1056/NEJMoa1912658 ↗
27. 10.1038/s41584-022-00888-z10.1038/s41584-022-00888-z ↗
28. 10.1038/s41584-021-00713-z10.1038/s41584-021-00713-z ↗
29. 10.1016/j.cell.2022.11.00110.1016/j.cell.2022.11.001 ↗
30. 10.1016/j.tcb.2018.02.00110.1016/j.tcb.2018.02.001 ↗
31. 10.1038/nature0720110.1038/nature07201 ↗
32. 10.1080/13510002.2022.204642310.1080/13510002.2022.2046423 ↗
33. 10.3389/fcell.2023.112763810.3389/fcell.2023.1127638 ↗
34. 10.1042/bj339048110.1042/bj3390481 ↗
35. 10.1113/JP28303910.1113/JP283039 ↗
36. 10.1101/cshperspect.a00506610.1101/cshperspect.a005066 ↗
37. 10.1038/s41556-018-0223-z10.1038/s41556-018-0223-z ↗
38. 10.1242/jcs.23943410.1242/jcs.239434 ↗
39. 10.1095/biolreprod.109.08002810.1095/biolreprod.109.080028 ↗
40. 10.15283/ijsc1807910.15283/ijsc18079 ↗
41. 10.1016/j.biopha.2018.01.03810.1016/j.biopha.2018.01.038 ↗
42. 10.1007/s13402-019-00486-410.1007/s13402-019-00486-4 ↗
43. 10.3390/cells1101003010.3390/cells11010030 ↗
44. 10.3390/ijms2105177210.3390/ijms21051772 ↗
45. 10.1016/j.joca.2017.07.02010.1016/j.joca.2017.07.020 ↗
46. 10.1038/nrm302810.1038/nrm3028 ↗
47. 10.1089/ars.2010.348210.1089/ars.2010.3482 ↗
48. 10.1242/jcs.09384910.1242/jcs.093849 ↗
49. 10.3389/fimmu.2023.125151710.3389/fimmu.2023.1251517 ↗
50. 10.1016/j.jconrel.2022.08.03310.1016/j.jconrel.2022.08.033 ↗
51. 10.1007/s00018-023-05067-110.1007/s00018-023-05067-1 ↗
52. 10.3389/fbioe.2022.88311810.3389/fbioe.2022.883118 ↗
53. 10.1016/j.jare.2022.01.00410.1016/j.jare.2022.01.004 ↗
54. 10.7150/thno.8903310.7150/thno.89033 ↗
55. 10.1016/j.redox.2021.10196310.1016/j.redox.2021.101963 ↗